We review our experience on Rifaximin in uncomplicated diverticular disease. Our data
show that a 2 week treatment induces modifications in the immune system: local mucosal
lymphocytes with TLR-4 were increased. In the peripheral blood CD103 cells, which increased before
treatment, returned to normal values after Rifaximin.
Keywords: Diverticular disease, rifaximin, mucosal immunity, TLR2, TLR4, T-lymphocytes.
Rights & PermissionsPrintExport